Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stocks to watch next week

Published 12/30/2017, 09:30 AM
Updated 12/30/2017, 09:30 AM
© Reuters.  Stocks to watch next week
  • Subscription notice: You can automatically receive Stocks to Watch every week by following the SA Stocks to Watch account and setting email alerts on.
  • What's next for investors after a stellar year for the Dow (+25%), S&P 500 Index (+20%) and Nasdaq (+28) was accompanied by dizzying gains for cryptocurrencies Bitcoin (+1395%), Ethereum (+8879%) and Litecoin (+5347%)? Not to sound too boring, but WTI crude oil futures ended the year up 43% from the 2017 low and gold capped off the year 15% above its low. While the upcoming week isn't loaded with earnings reports and events, there's some nuggets to dig through in the search for early 2018 stock movers, including sales reports from the Detroit Three and Palo Alto One.
  • IPO watch: No IPO filings are expected to be announced next week, but there are plenty of interesting names in the hopper for 2018. The list of IPO candidates includes Dropbox (Private:DROPB), Lyft (Private:LYFT), DocuSign (Private:ESIGN), Fanatics (Private:FANA), Xiaomo, 23andMe (Private:DNA), Coinbase (Private:COINB), SpaceX (Private:SPACE), Pinterest (Private:PINIT), Zscalar (Private:SCALE), Apttus, Zuora and Acquia.
  • Analyst quiet period expiration: Quanterix (Pending:QTRX), Curo Group (Pending:CURO), Odonate Therapeutics (Pending:ODT), Denali Therapeutics (Pending:DNLI), Luther Burbank (Pending:LBC) on Jan. 2.
  • IPO/secondary share lockup period expirations: Sage Therapeutics (NASDAQ:SAGE),Paramount Gold Nevada (NYSEMKT:PZG), Zogenix (NASDAQ:ZGNX), Intellia Therapeutics (NASDAQ:NTLA), NewLink Genetics (NASDAQ:NLNK) and Strongbridge Biopharma (NASDAQ:SBBP) on Jan. 2; CareDX (NASDAQ:CDNA), Rigel Pharmaceuticals (NASDAQ:RIGL), Tronox (NYSE:TROX) and US Gold (NASDAQ:USAU) on Jan. 3; Globalstar (NASDAQ:GSAT), ImmunoGen (NASDAQ:IMGN), Orion Engineered Carbons (NYSE:OEC) and Performance Food Group (NYSE:PFGC) on Jan. 4; Editas Medicine (NASDAQ:EDIT) and Black Knight (NYSE:BKI) on Jan. 5.
  • Notable earnings reports: Rite Aid (NYSE:RAD), Resources Connection (NASDAQ:RECN), MISTRAS Group (NYSE:MG) and Commercial Metals (NYSE:CMC) on Jan. 3; Walgreens Boots Alliance (NASDAQ:WBA), Sonic (NASDAQ:SONC), Monsanto (NYSE:MON) and Pricesmart (NASDAQ:PSMT) on Jan. 4; Constellation Brands (NYSE:STZ), Cal-Maine Foods (NASDAQ:CALM) and Greenbrier (NYSE:GBX) on Jan. 5.
  • Goldman Sachs (NYSE:GS) Healthcare CEOs Unscripted Conference: Due to speak at the healthcare event in Boston on Jan. 4 are execs from Eli Lilly (NYSE:LLY), Boston Scientific (NYSE:BSX), Humana (NYSE:HUM), Mylan (NASDAQ:MYL), AbbVie (NYSE:ABBV) and Alexion Pharmaceuticals (NASDAQ:ALXN).
  • Monthly sales reports/updates: Costco (NASDAQ:COST) and perhaps Macy's (NYSE:M) on Jan. 3; Buckle (NYSE:BKE), Cato (NYSE:CATO) and L Brands (NYSE:LB) on Jan. 4; perhaps J.C. Penney (NYSE:JCP) on Jan. 5.
  • Macau: Gaming revenue is expected to have increased 20% in December to mark the 17th straight month of positive growth. Estimates from analysts range from +13% to +25% to add some mystery to the upcoming report from the Macau Gaming Inspection & Coordination Bureau. The VIP segment continues to recover in the region, although some channel checks show a lower than normal hold rate for December. Expect some trading action with Wynn Macau (OTCPK:WYNMF, OTCPK:WYNMY, WYNN), Sands China (OTCPK:SCHYY, OTCPK:SCHYF, LVS), MGM China (OTCPK:MCHVF, OTCPK:MCHVY, MGM), Galaxy Entertainment (OTCPK:GXYEF), SJM Holdings (OTCPK:SJMHF, OTCPK:SJMHY) and Melco Resorts & Entertainment (NASDAQ:MLCO) after the revenue numbers post. The VanEck Vectors Gaming ETF (NYSEARCA:BJK) could also see some movement.
  • Auto sales reports: Kelley Blue Book expects U.S. auto sales to fall 7% in December to 1.57M units as the industry bumps up against a tough incentives-driven comparable from a year ago. Forecast by automaker - General Motors (NYSE:GM) -7.9% to 294K, Ford (NYSE:F) -2.4% to 232K, Toyota (NYSE:TM) -9.6% to 220K, Fiat Chrysler (NYSE:FCAU) -11.7% to 170K, Honda (NYSE:HMC) -5.3% to 152K, Nissan (OTCPK:NSANY) -5.7% to 144K, Hyundai (OTCPK:HYMLF) -9.1% to 106K, Subaru (OTCPK:FUJHY) -6.6% to 59K, Volkswagen (OTCPK:VLKAY) -10.8% to 57.5K. An update from Tesla (NASDAQ:TSLA) on Q4 deliveries is also due next week. The consensus estimate stands at 5.2K Model 3 deliveries and 26.6K Model S/X deliveries.
  • Barron's mentions: GlaxoSmithKline (NYSE:GSK) is tapped for a "speedy recovery" and bitcoin is said to be "here to stay" in case you were worried. Meanwhile, there's a prediction that Facebook (NASDAQ:FB) could be the first FANG stock to pay a dividend and that investors may need to deal with inflation in 2018.
  • Sources: CNBC, EDGAR, Bloomberg and Nasdaq.com.
  • Now read: Are Tesla Bears Hibernating?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.